Beacon Capital Management LLC (Tennessee)’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-28
Closed -$2.34K 635
2025
Q2
$2.34K Hold
28
﹤0.01% 880
2025
Q1
$2.36K Hold
28
﹤0.01% 908
2024
Q4
$2.58K Hold
28
﹤0.01% 845
2024
Q3
$2.6K Hold
28
﹤0.01% 935
2024
Q2
$2.31K Hold
28
﹤0.01% 839
2024
Q1
$1.86K Buy
+28
New +$1.73K ﹤0.01% 887

Other funds holding LMAT

Beacon Capital Management LLC (Tennessee)'s LMAT Position: Q3 2025 in Review

Beacon Capital Management LLC (Tennessee) sold out of LeMaitre Vascular (LMAT) in Q3 2025, closing a stake of 28 shares — an estimated $2.34K sold.

Beacon Capital Management LLC (Tennessee) first reported a position in LMAT in Q1 2024 and held it in 6 quarters. The position peaked at $2.6K in Q3 2024. 297 funds tracked by Wall St. Rank hold LMAT as of Q3 2025.

  • Beacon Capital Management LLC (Tennessee) reported no remaining LeMaitre Vascular position as of Q3 2025 after selling out during the quarter.
  • Beacon Capital Management LLC (Tennessee) sold 28 LeMaitre Vascular shares in Q3 2025, an estimated $2.34K.
  • Beacon Capital Management LLC (Tennessee) first reported a position in LeMaitre Vascular in Q1 2024 and held it in 6 quarters.
  • Beacon Capital Management LLC (Tennessee)'s LeMaitre Vascular position peaked at $2.6K in Q3 2024.
  • 297 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2025.

Based on Beacon Capital Management LLC (Tennessee)'s 13F filing for Q3 2025, filed 7 Nov 2025.